Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has emerged over the past two decades. The prostate is a small gland that sits ...

Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of testosterone therapy: cancer! I survived advanced prostate cancer seven years ...

The testosterone threshold should be less than 10 ng/dL rather than less than 50 ng/dL for gauging advanced prostate cancer prognosis in patients on ADT. Examining sustained testosterone suppression ...

Scientist hand holding test tube with blood in laboratory. Local testosterone delivery to the prostate bed might be a better marker of post-prostatectomy outcomes than serum testosterone in some men.

Men treated with testosterone replacement therapy (TRT) for hypogonadism didn't have an increase in adverse prostate events, the TRAVERSE trial found. Over a mean follow-up of 33 months, those who ...